Texto: 
renal chromophobe carcinoma eosinophile type that perforates renal capsule and infiltrates perirenal fat tissue
treated with left radical nephrectomy
• scout abdominal scan from a comuter tomography  demonstrates a radio-opaque lobular mass  projected in the left renal fossa. 

• mdct shows a heterogeneous mass arising from the left kidney
• there is irregular enhancement after iv contrast
chromophobe renal cell carcinoma, eosinophile type, that perforates renal capsule and infiltrates perirenal fat tissue
• renal cell carcinoma
* oncocytoma
• transitional cell carcinoma
40 y.o. woman with evolution over one month or lower urinary tract symptoms, left renal pain, hematuria, and no improvement with treatment.
renal cell carcinoma:
incidence 80-90% of all renal malignant primaries in adults.
arises from proximal tubular cells; 30% found incidentally with imaging.
tumor growth pattern: papillary (best prognosis); trabecular/tubular/cystic/solid (poorer prognosis). predisposing factors: tobacco, von hippel-lindau disease, hemodialysis, acquired cystic disease of uremia.
the most common sites of metastases are the lung (55%), lymph nodes, liver, bone, adrenals, contralateral kidney, brain, heart, spleen. it?s important to know that 28% of patients have clinically apparent multiple distant metastases at presentation! 
radiology findings in ct: mostly hterogeneous enhancement (due to cystic areas or necrosis), subcapsular/perinephric hemorrhage. mri best modality to assess stage iii+iv disease: low to medium signal intensity on t1wi; hyperintense areas are usually due to hemorrhage. heterogeneous signal intensity on t2wi.
staging:
    i: confined to within renal capsule
   ii: extension into perinephric fat but confined to gerota fascia
  iiia: extension into renal vein or ivc
 iiib: positive lymph nodes
 iiic: extension into renal vein + lymph nodes
 iva: extensio into adjacent organs( other than ipsilateral adrenal)
 ivb: distant metastases

treatment and prognosis: recurrence in 11% after 10 years. radical nephrectomy has a 2-5% operative mortality. tumor stage and histological grade are the most important prognosticators!

chromophobe carcinoma of kidney:

a distinct type of renal cell carcinoma
5% all
males= females in contradistinction to classic rcc where male 2-3:1 females
unlike other renal cell carcinomas can be hypovascular on imaging
birt-hogg-dube syndrome a risk factor for chromophobe renal cell carcinoma and these patients need to be screened
can look identical to oncocytoma, and in case reports has coexisted with this.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term=renal+chromophobe+carcinoma&tool=querysuggestion


Keywords by value: 
- renal: 0.08654411964465401 (1899)
- chromophobe: 0.07924061504688988 (5)
- carcinoma: 0.04354027271938637 (1515)
- :: 0.04063909450752953 (11095)
- eosinophile: 0.03962030752344494 (2)
- cell: 0.03630940445184361 (1988)
- perforates: 0.03468272420358826 (4)
- %: 0.031355611760498996 (2175)
- capsule: 0.03118559785577577 (112)
- perirenal: 0.028843250117609565 (15)
- prognosis: 0.027325917904508373 (166)
- nodes: 0.02602039123392295 (222)
- !: 0.025727981890373855 (28)
- oncocytoma: 0.02497717701548322 (38)
- metastases: 0.02461167943849203 (266)
- radical: 0.02404396638726639 (48)
- infiltrates: 0.02390566679775289 (38)
- lymph: 0.023255342082772898 (1772)
- confined: 0.023154861922862258 (48)
- distant: 0.022412930460572602 (58)
- nephrectomy: 0.021776298923210684 (80)
- females: 0.021371125453573392 (63)
- extension: 0.020564004412460587 (611)
- kidney: 0.02029471992168546 (1021)
- &: 0.020234075677357966 (872)
- comuter: 0.01981015376172247 (1)
- trabecular/tubular/cystic/solid: 0.01981015376172247 (1)
- hterogeneous: 0.01981015376172247 (1)
- subcapsular/perinephric: 0.01981015376172247 (1)
- iii+iv: 0.01981015376172247 (1)
- extensio: 0.01981015376172247 (612)
- prognosticators: 0.01981015376172247 (1)
- males=: 0.01981015376172247 (1)
- 2-3:1: 0.01981015376172247 (2)
- birt-hogg-dube: 0.01981015376172247 (1)
- coexisted: 0.01981015376172247 (1)
- term=renal+chromophobe+carcinoma: 0.01981015376172247 (1)
- type: 0.01941993861806906 (949)
- into: 0.018277090947952424 (1299)
- tool=querysuggestion: 0.018252519648104613 (3)
- •: 0.01760690282692009 (8449)
- fat: 0.017520757232909887 (1111)
- radio-opaque: 0.01734136210179413 (4)
- iiic: 0.01734136210179413 (3)
- important: 0.017252964860880557 (193)
- projected: 0.01669488553448676 (4)
- stage: 0.016382177208666727 (467)
- primaries: 0.0161934393517582 (5)
- poorer: 0.0161934393517582 (5)
- uremia: 0.0161934393517582 (5)
- adrenals: 0.0161934393517582 (6)
- iiia: 0.0161934393517582 (7)
- iva: 0.0161934393517582 (330)
- ivb: 0.0161934393517582 (5)
- cmd=search: 0.0161934393517582 (6)
- best: 0.0161580341523064 (312)
- contradistinction: 0.015783727988176278 (6)
- mdct: 0.015437321966092552 (10)
- hypovascular: 0.015437321966092552 (11)
- iiib: 0.015137251420868905 (11)
- screened: 0.015137251420868905 (13)
- //www.ncbi.nlm.nih.gov/entrez/query.fcgi: 0.015137251420868905 (11)
- ?: 0.014988222474716885 (590)
- gerota: 0.014872570441865796 (13)
- 80-90: 0.014635805238140344 (10)
- 2-5: 0.014635805238140344 (23)
- hemodialysis: 0.014226093874558423 (19)
- heterogeneous: 0.014122225423797779 (406)
- vein: 0.0138963295371421 (782)
- intensity: 0.013881665961255287 (622)
- db=pubmed: 0.013879687852474697 (20)
- medium: 0.013724647691829862 (23)
- ;: 0.013654524865972541 (2912)
- predisposing: 0.01357961730725105 (18)
- identical: 0.013193436954606874 (25)
- hippel-lindau: 0.013078171124522489 (33)
- evolution: 0.012968530306164214 (24)
- rcc: 0.012968530306164214 (37)
- areas: 0.012922908634813785 (527)
- hemorrhage: 0.01278317565921814 (714)
- know: 0.012764099343904156 (820)
- fascia: 0.012764099343904156 (59)
- carcinomas: 0.012322053738856842 (46)
- scout: 0.012167013578212007 (31)
- perinephric: 0.012167013578212007 (55)
- von: 0.012093328583104163 (53)
- unlike: 0.012093328583104163 (172)
- histological: 0.011952833398876445 (58)
- t1wi: 0.011820607556128281 (50)
- transitional: 0.011757302214630087 (54)
- tobacco: 0.011577430961431129 (47)
- arises: 0.011520537010904634 (41)
- t2wi: 0.011520537010904634 (50)
- distinct: 0.01141089619254636 (115)
- mostly: 0.011206465230286301 (49)
- cystic: 0.011077000931468578 (1209)
- staging: 0.011064490170462633 (65)
- ipsilateral: 0.011064490170462633 (74)
- organs: 0.011019090828176073 (60)
- ,: 0.010950070065867804 (45533)
- all: 0.010862577480590071 (11660)
- lobular: 0.010846144668319605 (121)
- *: 0.010685562726786696 (276)
- look: 0.010685562726786696 (125)
- contralateral: 0.010609379464594153 (72)
- modality: 0.010535694469486307 (70)
- sites: 0.01046434908001534 (111)
- mortality: 0.01046434908001534 (75)
- operative: 0.010361406302416928 (439)
- spleen: 0.01032811397480987 (113)
- acquired: 0.010295307683975819 (85)
- enhancement: 0.010294331533137241 (898)
- tomography: 0.010262973442510426 (87)
- due: 0.010248436642484673 (1041)
- ivc: 0.010231097858258839 (145)
- signal: 0.010126176765270917 (1276)
- that: 0.009950431877924652 (3273)
- patients: 0.009939661120746185 (1457)
- +: 0.009907413880229764 (574)
- adults: 0.009800384556658406 (108)
- factor: 0.009800384556658406 (351)
- papillary: 0.009748722717951217 (172)
- adrenal: 0.009723330458953615 (264)
- assess: 0.009624536923175825 (253)
- to: 0.009597036144786207 (40381)
- need: 0.009576722544642603 (467)
- disease: 0.009416208143027219 (3336)
- 55: 0.009309414807875487 (215)
- hematuria: 0.009108639301502791 (175)
- tissue: 0.00910301657731503 (1668)
- 28: 0.009051745350976298 (276)
- imaging: 0.008998084604294845 (1530)
- improvement: 0.008960010531829658 (161)
- tumor: 0.008953853040947467 (2333)
- tubular: 0.008942104532618024 (175)
- urinary: 0.008889227010347923 (210)
- most: 0.00886667479428349 (1722)
- other: 0.00885230808405595 (2604)
- incidence: 0.008803772188799072 (176)
- 11: 0.008787064371973189 (860)
- can: 0.008711111696490201 (6061)
- incidentally: 0.008705339328892572 (149)
- factors: 0.008626482430440278 (203)
- left: 0.008594204667621706 (7401)
- from: 0.008537768852725027 (3282)
- tract: 0.008505798882188905 (565)
- apparent: 0.00849115914955701 (196)
- clinically: 0.008419357801677005 (178)
- recurrence: 0.00837735300839127 (207)
- growth: 0.00834977976661191 (284)
- ii: 0.00828229148099646 (783)
- (: 0.008116423890380454 (9594)
- radiology: 0.008115756712111693 (259)
- 40: 0.0080790170761532 (508)
- ): 0.008017277439475338 (10569)
- hyperintense: 0.007972270258209372 (240)
- arising: 0.007949221943226925 (227)
- after: 0.007946072820715517 (1714)
- i: 0.00793778583197418 (513494)
- are: 0.007853082286716417 (8518)
- where: 0.007837398326240265 (359)
- fossa: 0.007826516024047481 (300)
- treatment: 0.0077735593689927515 (1790)
- reports: 0.007741304260311991 (419)
- cells: 0.007699880211573028 (362)
- irregular: 0.007659205960688494 (401)
- necrosis: 0.007580001603246528 (442)
- 30: 0.007384470419000169 (631)
- classic: 0.007357876132152972 (354)
- pattern: 0.007340319863081525 (355)
- grade: 0.007314239984159484 (661)
- http: 0.00727143505164107 (550)
- has: 0.007212134698850688 (2768)
- iv: 0.0070076964886766156 (11885)
- risk: 0.006955520555863117 (538)
- malignant: 0.006940832980627643 (482)
- or: 0.006751838757058703 (60128)
- heart: 0.006672089098671403 (585)
- liver: 0.006620722496253312 (910)
- presentation: 0.006614383448294568 (453)
- 10: 0.006473312872689686 (1995)
- positive: 0.006231203573672173 (589)
- adjacent: 0.006071542121650039 (562)
- found: 0.006051742953824972 (642)
- be: 0.005922502127388446 (14541)
- usually: 0.005831299446891594 (770)
- brain: 0.005778318029893848 (978)
- proximal: 0.005765265576869697 (840)
- month: 0.00576093155236092 (1567)
- treated: 0.005747979406930021 (646)
- in: 0.00568176040638546 (113220)
- years: 0.005638748622513444 (760)
- 5: 0.0056183380279644125 (8237)
- lung: 0.005562155326379205 (1511)
- y.o: 0.005542425691206068 (586)
- s: 0.005507343072167612 (414481)
- syndrome: 0.0054919248915385206 (1256)
- scan: 0.0053758909223213 (1175)
- a: 0.0053474130582283315 (549576)
- mass: 0.005341397784033999 (5255)
- low: 0.005339703489587415 (6753)
- shows: 0.005279491460064897 (912)
- one: 0.0052038907490126836 (7087)
- than: 0.005031570460490503 (1107)
- common: 0.005025319577430107 (1580)
- these: 0.0049974038021524505 (1129)
- over: 0.004889084472224635 (1978)
- on: 0.0048801641283062564 (91641)
- abdominal: 0.004799818512633967 (1376)
- symptoms: 0.004785747139096942 (1259)
- bone: 0.004771763329123303 (2205)
- woman: 0.004435736960649228 (987)
- mri: 0.004411855853740719 (1820)
- lower: 0.004318791167109804 (1849)
- it: 0.004316513223669701 (53878)
- contrast: 0.004298372329905406 (1844)
- case: 0.004201133557005103 (2053)
- demonstrates: 0.004194654385737497 (1423)
- have: 0.004158287816550768 (1751)
- but: 0.004095513036030422 (2727)
- findings: 0.004087274013011145 (1669)
- multiple: 0.004044507872987121 (1682)
- within: 0.0036632166480586106 (1927)
- male: 0.003472371995252749 (2906)
- there: 0.0028577877673370534 (3976)
- and: 0.00283160233736074 (31978)
- ct: 0.0026860756256000965 (27172)
- at: 0.002601714950183445 (83424)
- pain: 0.002345186893327494 (5051)
- this: 0.0021598589063238946 (5602)
- no: 0.0019335823611321395 (35870)
- for: 0.001638445277848798 (12260)
- of: 0.0015708377635683833 (41955)
- the: 0.0015533627494789416 (67588)
- with: 0.0013146536639313453 (23954)
- is: 0.001263574782887024 (65037)
- .: 0.0011168393378940401 (82185)
